Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-26 @ 3:16 PM
NCT ID:
NCT07331103
Eligibility Criteria:
Inclusion Criteria:
* Participants are subjects \>55 y old from both sexes (\>=40% women) with moderate to high cardiovascular risk (ANNEX 1: SCORE2, SCORE2-OP and SCORE2-Diabetes assessment).
Exclusion Criteria:
* cardiovascular disease,
* established atherosclerotic vascular disease involving the coronary, peripheral, carotid, or aortic territories (identified by computerized tomography (CT) of coronary arteries, MRI, carotid or peripheral ultrasound imaging),
* chronic treatment with n-3 PUFA containing products (i.e., Vazkepa),
* a condition that interferes with the possibility to follow the dietary intervention, such as fish allergy or being a vegan,
* significant liver dysfunction,
* participation in another intervention clinical study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
55 Years
Study:
NCT07331103
Study Brief:
Protocol Section:
NCT07331103